Inhibitors of inflammation and reperfusion injury and methods of use thereof
AssigneeInotek Corporation
InventorsPrakash Jagtap, Garry Southan, Andrew Salzman, Csaba Szabo, Siya Ram
Life of this patent
Estimating the term…
Abstract
The invention provides a novel class of substituted isoindolinone derivatives. Pharmaceutical compositions, and methods of making and using the compounds, or pharmaceutically acceptable salts, hydrates, prodrugs, or mixtures thereof are also described.
Claims29
A compound of Formula IV:
- 52
- or a pharmaceutically acceptable base or acid addition salt, hydrate, ester, solvate, prodrug, metabolite, stereoisomer, or mixtures thereof, wherein:
- Y is O, OH, S, Se, NH, N-alkyl, N-aryl;
- R11 is H, OH, aryl, alkyl, or an amino acid side chain;
- R12 and R13 are, independently, hydrogen, alkyl, aryl, heterocycle, OH, O-alkyl, O-aryl, N-alkyl, N-aryl, or, taken together ═O, ═NH, ═S;
- R14, R15, R16, and R17 are, independently, hydrogen, halo, alkylhalo, hydroxy, alkoxy, C1-C10 straight or branched chain alkyl group, C2-C10 straight or branched chain alkenyl group, C3-C8 carbocyclic, aryl, alkylamino, amino, carboxy, ester, arylalkyl, nitro groups;
- or R13, and R14 taken together, form a heterocyclic or a carbocyclic ring;
- or R14, R15, R16, and R17 are, independently, H, or Q-B—C;
- wherein Q is NHCO, NHCONH, O, CO, OCO2, OCO, OCONH, NH, CH2, CH-alkyl, NHCO2, S, SO2, CS, SO;
- B is C1-C10 straight or branched chain alkyl, C2-C10 straight or branched chain alkenyl group, C3-C8 carbocyclic, aryl, alkylamino, amino, alkylamido, arylamido, carboxy, ester, anhydride, or arylalkyl group substituted with hydrogen, halogen, alkylhalo, hydroxy, nitro, amino, amido, carbamate, or carbonate;
- C is a substituted carboxy, amido, hydroxy, carbocyclcle or heterocycle, heterocyclic or carbocyclic amine group, or a straight or branched chain alkyl amine,
- wherein said substitutions are selected from the group consisting of:
- hydrogen, alkylhalo, alkylhydroxy, C1-C10 straight or branched chain alkyl, C2-C10 straight or branched chain alkenyl group, C2-C10 straight or branched chain alkynyl group, C3-C8 carbocyclic, aryl, benzyl, alkylamino, alkylamido, alkylcarboxy, alkylester, arylalkyl, or cyclic heterocyclic amines, and
- wherein said heterocyclic amines are selected from the group consisting of piperidine, piperazine, N-alkylated or alkylcarbonylated piperazines, pyrole, imidazole, benzimidazole, tetrazoles, indole, isoquinoline, quinoline, pyrrolidine, aniline, substituted aniline, purine, nucleosides, nucleotides, sugars, hydroxylates alkanes, glycerol, C2 to C10 branched or cyclic or cycloalkenyl amines, and heterocyclic compounds.
The compound of claim I wherein Y═O, R11, R12, R13, R15, R16, R17═H and R14 is selected from the group consisting of H, F, NO2, NH2, HCOCH2Cl, NHCOCH2N(CH3)2, NHCOCH2N(CH2CH3)2, NHCOCH2N(CH3)-piperazine, NHCOCH2CH2CH2N(CH3)-piperazine, NHCOCH2NH(CH2CH3), NHCOCH2-piperidine, NHCOCH21,2,3,4-tetrahydroisoquinoline, NHCOCH2N(CH3)CH2Ph, NHCOCH2(S)-prolinol, NHCOCH2-9-adenine, NHCOCH2-9-(6-chloropurine), NHCOCH2-9-(6-N,N-dimethylpurine), NHCOCH2-benzimidazole, NHCOCH2-ethylnipecotate, NHCOCH2-morpholine, NHCOCH2-pyrrolidine, NHCOCH2-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline, NHCOCH24-indolemethylester, NHCO-m-NO2-benzoyl, NHCOCH2CH2COOC(NH-cyclohexyl)2, OH, OCH3, OCH2COOCH3, OCH2COOH, OCH2CO-1,2,3,4-tetrahydroisoquinoline, OCO-m-NO2-benzoyl, CH2NH2, CH2NHCO-m-NO2-benzoyl, NHCOCH2CH2CH2COOH, NHCOCH═CHCOOH, NHCOCH2CH2CO-1,2,3,4-tetrahydroisoquinoline, NHCOCH2CH2CH2CO1,2,3,4-tetrahydroisoquinoline, NHCOCH2CH2OH, NHCOCH2CH2CH2OH, NHCONH-cyclohexyl, NHCO(CH2)4NHtBOC, NHCOCH2CH2CH2CH2NH2, NHCOCHNHtBoc(CH2)3-NH—C═NHNtBoc), NHCOCHNH2(CH2)3-guanidine, NHCOCHNHtBoc(5-CH2—N-tBoc-imidazole), NHCOCHNHtBoc(3-CH2-indole), NH-prolinyl, NH-nipecotyl, NH-3,4,5-trimethoxybenzoyl, NHCOCH2CH2CONH(2-CH2-benzimidazole), NHCO(CH2)2CONH(CH2)2-piperidine, NHCO(CH2)2CONH(CH2)2-piperidine, NHCO(CH2)2CONH(CH2)2-2-pyridine, NHCOCH(NHCOOC7H7)(CH2)4NHtBoc, NHCOCH(NHCOOC7H7)(CH2)4NH2, NHCOCH2COOH, NHCO(CH2)2COOH, NHCO(CH2)3COOH, NHCO(CH2)3COOH, NHCO(CH2)4COOH, NHCO(CH2)5COOH, NHCO(CH2)6COOH, NHCO(CH2)7COOH, NHCO(CH2)8COOH, NHCO(CHOAc)2COOH, NHCO(CF2)3COOH, NHCONHCH2COOH, NHCOCH2OCH2COOH, NHCOCH2NH2, NHCOCH2CH2NH2, NHCOCH(CH3)NH2, NHCOCH2NHCH3, NHCOCH2CH2NHCH3, NHCOCH2tBOC-piperazine, NHCOCH2-piperazine-HCl, NHCO(CH2)7NHCH3, NHCOCH2CO-piperazine-HCl, NHCOCH2CH2Cl, NHCOCH2CH2CH2Cl, NHCOC6H4COCH═CHCOOH, NHCO(2,5-difluorophenyl)COOH, NHCOCH2COOCH3, NHCO(CH2)2COOCH2CH3, NHCOCO COOCH3, NHCO(CH2)4COOCH3, NHCO(CH2)CH3, NHCO(CH2)6COOCH3, NHCO(P—C6H4-CH═CHCOOCH2CH3), NHCO(CH2)8COOCH3, NH(2-thiophenoyl), NH(2-furoyl), NH(m-chloromethylenebenzoyl), NH(m-N,N-diethylmethylenebenzoyl), NH(m-NHCOCH2Cl-benzoyl), NH(m-NHCOCH2N(CH2CH3)2-benzoyl), NH(m-NHCOCH2N(CH3)2-benzoyl), NH-[m-CH2-(2-hydroxymethylenepyrrolidine)-benzoyl], NH-[m-CH2-(1,2,3,4-tetrahydroisoquinoline)-benzoyl], NHCOCH2-isoindoline, NH-2-carboxybenzoyl, and NHCOCH2CH(OTBDMS)—CH2COOH.
A compound of formula I:
- A-Z1-L-Z2-G I:
- or a pharmaceutically accepted prodrug, hydrated salt, or mixtures thereof, wherein:
- A and G are connected via Z1 and Z2 respectively, to a linker, L;
- A is selected from the group consisting of Formulas II and III;
- 53
- wherein,
- X1 and X2 are, independently, N or CH,
- X3 is CR7═CR8, CHR7—CHR8, CR7═N, N═CR7, N═N, NR7—O, CHR7—O or CHR7—S, where R7 and R8 are, independently, H, alkyl, amino, substituted amino, hydroxy, or alkoxy;
- R1 and R2 are independently H, alkyl, NH2, OH, SH, Cl, NHR9, N═R9, N═NR9, or amide, where R9 is alkyl, aryl, arylalkyl, alkyl-heterocycle;
- R3 and R4 are independently H, hydroxy, C1-5 alkyl, amino, or halo;
- R5 and R6 are independently alkyl, acetyl, other acyl, or R5 and R6 taken together form a 5-or 6-membered optionally substituted heterocycle;
- Z1 is —CH2O—, —CH2NR10—, —CH2NR10C(O)—, —CONR10—, —CO2—, —CH2NHCONH—, —CH2—, —CH2NHCSNH—, —CO—, —CH2CO2—, —NHCO2, S, SO2, CH2S, or SO;
- Z2 is;
- —NR10CO—, —C(O)NR10—, —NHCONH—, —OC(O)—, —C(O)O—, NHCS, —CSNH—, NHCSNH, O, CO, OCO, OCONH, NH, CH2, CH-alkyl, NHCO2, S, SO2, CS, or SO;
- L is H, O, S, C1-15 alkylene chain optionally substituted in one or more positions, or a 5, 6 or 7 membered carbocycle or heterocycle optionally substituted in one or more positions, provided that L is not H when Z1 is O, and when L=H, Z2 and G are absent, and
- G is H, OH, SH, NH2, CO2H, unsubstituted or substituted alkyl, aryl, alkylaryl, carbocyclic, heterocyclic, bicyclic, bicyclic heterocycle, biphenyl or heterocyclic amines such as piperidine, piperazine, pyrole, imidazole, benzimidazole, tetrazoles, indole, isoquinoline, quinoline, or pyrrolidine.
Dependencies are inferred from the claim text.